# Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation

> **NCT01603030** · PHASE3 · UNKNOWN · sponsor: **Adapt Produtos Oftalmológicos Ltda.** · enrollment: 66 (estimated)

## Conditions studied

- Eye Infection/Inflammation Other

## Interventions

- **DRUG:** moxifloxacin 0,5% + prednisolone 1%
- **DRUG:** moxifloxacin/prednisolone combination

## Key facts

- **NCT ID:** NCT01603030
- **Lead sponsor:** Adapt Produtos Oftalmológicos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2012-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603030, "Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01603030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*